ABSTRACT Reporter-expressing recombinant influenza A viruses (IAVs) have emerged as powerful tools for studying viral infection, host–pathogen interactions, and the identification and characterization of prophylactic and/or therapeutic countermeasures for the treatment of IAV infections. By incorporating a reporter gen...
Ramya S. Barre, H. Nath, A. Nogales et al.· Journal of Virology· 0 citations
Proof of concept is provided for the use of codon deoptimization (CD) as a rational strategy to generate attenuated RVFV, for the development of next-generation vaccines against this zoonotic threat.
Sandra Moreno, Alejandro Cenalmor, Celia Alonso et al.· bioRxiv· 0 citations
The development and implementation of this multivalent LAIV as a broadly protective pan-H5N1 LAIV for pandemic preparedness are supported and the feasibility of developing and implementing this multivalent LAIV as a broad protective pan-H5N1 LAIV against divergent H5N1 viruses for human use is demonstrated.
Ahmed M. Elsayed, Ramya S. Barre, Arash Rahmani et al.· bioRxiv· 0 citations
Current evidence on cross-reactive and cross-protective immunity to H5N1 in humans, focusing primarily on humoral immune responses is summarized, and particular attention is given to antibodies targeting conserved regions of hemagglutinin (HA) as well as neuraminidase (NA), which may provide heterosubtypic protection.
Iván Sanz-Muñoz, Carlos J. Ciria-Gil, Marta Hernández et al.· Journal of Infection· 0 citations
Using the ferret model of influenza infection and transmission, it is demonstrated that the currently circulating B3.3.13 is already well adapted for mammalian infection and transmission whereas D1.1 rapidly acquires mammalian-adaptive mutations after a single infection and/or transmission event, highlighting its evolu...
Ahmed M. Elsayed, Ramya S. Barre, Mahmoud Bayoumi et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.